Product Information
EVEROLIMUS 0.25 MG TABLET is a generic product labeled by Biocon Pharma Inc., priced at $1.9762 per EA under NDC 70377006911. Its NADAC has been published 42 times since Nov 5, 2025.
FDA first approved this application on Apr 9, 2025. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
.25 mg/1
Manufacturer
Biocon Pharma Inc.NDC
70377006911
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
EVEROLIMUSApproval Type
Generic (ANDA)
FDA Application
ANDA216140FDA Approved
4/9/2025
TE Code
AB
On Market Since
6/2/2025
Pharmacological Classes
Price Statistics
The NADAC for EVEROLIMUS 0.25 MG TABLET has been published 42 times since Nov 5, 2025, and over the history we have for it it has declined 11.8%. The table below summarizes its recorded NADAC range and movement.
| Current price | $1.9762 per EA |
|---|---|
| All-time high | $2.3327 (Feb 11, 2026) |
| All-time low | $1.9762 (Aug 19, 2026) |
| 52-week high | $2.3327 |
| 52-week low | $1.9762 |
| Median price | $2.2403 |
| Average price | $2.2097 |
| Largest weekly change | -6.6% (Aug 19, 2026) |
| Weeks tracked | 42 |
| Tracking since | Nov 5, 2025 |
Generic Alternatives
The matcher finds 3 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of EVEROLIMUS 0.25 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for EVEROLIMUS 0.25 MG TABLET, manufactured by Biocon Pharma Inc., is $1.9762 per EA (NDC 70377006911), effective Aug 19, 2026.
How has the price of EVEROLIMUS 0.25 MG TABLET changed over time?
Over the history we have for it, the NADAC for EVEROLIMUS 0.25 MG TABLET has declined 11.8%. It has been tracked across 42 weekly CMS publications since Nov 5, 2025.
What are the highest and lowest recorded NADAC prices for EVEROLIMUS 0.25 MG TABLET?
Since Nov 5, 2025, the NADAC for EVEROLIMUS 0.25 MG TABLET has ranged from a low of $1.9762 (Aug 19, 2026) to a high of $2.3327 (Feb 11, 2026), with a median of $2.2403 per EA.
Are there cheaper alternatives to EVEROLIMUS 0.25 MG TABLET?
3 manufacturers publish a NADAC-priced product with the same active ingredient and strength as EVEROLIMUS 0.25 MG TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures EVEROLIMUS 0.25 MG TABLET?
EVEROLIMUS 0.25 MG TABLET (NDC 70377006911) is labeled by Biocon Pharma Inc., and CMS classifies it as a generic product.